These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6440695)

  • 1. [Identification of beta-lactamases of gram-negative bacteria and antibacterial activity of furbenicillin to this strain of bacteria].
    Li JT; Yang YJ
    Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):486-9. PubMed ID: 6440695
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
    Yang YJ; Li JT
    Chin Med J (Engl); 1984 May; 97(5):345-51. PubMed ID: 6439485
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of mecillinam against ESBL producers in vitro.
    Thomas K; Weinbren MJ; Warner M; Woodford N; Livermore D
    J Antimicrob Chemother; 2006 Feb; 57(2):367-8. PubMed ID: 16354745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and antibacterial activity of benzoylaminoacyl-penicillins and related compounds with and without acylated catechol substituents].
    Heinisch L; Ulbricht H; Willitzer H; Hanschke KG; Tresselt D; Möllmann U; Eckardt K; Haupt I
    Arzneimittelforschung; 1992 May; 42(5):668-73. PubMed ID: 1530682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase as biochemical parameter of antibiotic resistance.
    Lin JK; Hou TT
    Taiwan Yi Xue Hui Za Zhi; 1985 Dec; 84(12):1334-43. PubMed ID: 3879690
    [No Abstract]   [Full Text] [Related]  

  • 7. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of multidrug resistant Gram-negative bacilli by Cica-Beta-Test strips.
    Lavigne JP; Pfeiffer C; Vidal L; Sotto A
    Pathol Biol (Paris); 2011 Feb; 59(1):e7-11. PubMed ID: 20828939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp.
    Theron MM; van Rensburg MN; Chalkley LJ
    J Antimicrob Chemother; 2003 Jul; 52(1):120-2. PubMed ID: 12805259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum beta-lactamases in lower respiratory tract infection].
    Long J; Lü SC
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):439-40, 444. PubMed ID: 15090319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
    Betriu C; Palau L; Gómez M; Sánchez A; Romero J; Picazo JJ
    Rev Clin Esp; 1999 Aug; 199(8):503-10. PubMed ID: 10522430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Rahal JJ
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Emergence of AmpC enzyme and antibiotics resistance in gram-negative bacilli].
    Liu WE; Jiang Y; Tang Y; Wang HM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):134-7. PubMed ID: 16562695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the new quinolones: an overview.
    Garcia-Rodriguez JA
    J Chemother; 1989 Jul; 1(4 Suppl):136-8. PubMed ID: 16312340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L; Marín M; Stamboulian D
    Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of beta-lactamase inhibitors among representatives of the genus Micromonospora and the genus Streptoverticillium].
    Bibikova MV; Ivanitskaia LP; Nikishina VG; Rybakova AM
    Antibiotiki; 1983 Sep; 28(9):665-71. PubMed ID: 6605711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.